Oct 10 2024 - Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®,...
Sep 25 2024 - Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application...
Sep 3 2024 - Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business...
Aug 6 2024 - Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows...